Beyond GLP 1s: Why Older Appetite Suppressants Like Phentermine and Diethylpropion Still Matter in Obesity Care
Quick answer: GLP 1 medicines such as semaglutide and tirzepatide have transformed obesity treatment, but they are not right for everyone. Older appetite suppressants like phentermine and diethylpropion still matter because they are oral, fast acting, affordable and suited to short, structured courses. For patients who cannot tolerate, access or afford GLP 1 therapy, or who simply prefer a tablet, these medicines remain a valid option when prescribed safely and monitored closely.
The GLP 1 Revolution and Its Limits
Few developments in modern medicine have attracted as much attention as GLP 1 based weight loss treatments. These medicines mimic natural gut hormones that regulate appetite, slow stomach emptying and help control blood sugar. In large clinical trials, many patients lost 15 percent or more of their body weight, results previously seen only with bariatric surgery.
It is no surprise that searches for Weight Loss Injections UK have soared. Yet the rapid rise of these treatments has also exposed their limitations. Obesity is a complex, chronic condition, and no single medicine suits every person. A modern approach to obesity care recognises that a broader toolkit gives patients and clinicians more room to find what genuinely works.
This is where older appetite suppressants deserve a fresh look.
What Are Phentermine and Diethylpropion?
Phentermine and diethylpropion are sympathomimetic amines, first approved in the late 1950s. They act on the central nervous system, increasing the activity of noradrenaline in the brain. This triggers a mild stimulant effect that reduces hunger and helps people feel satisfied with smaller portions.
Both medicines are typically prescribed for short courses, often up to twelve weeks, alongside a reduced calorie diet, increased physical activity and behavioural support. In the UK, neither currently holds a marketing authorisation, so they are prescribed privately as unlicensed medicines by qualified clinicians. Both are also controlled drugs, which means prescribing is carefully regulated.
Phentermine is generally considered the more potent of the two, while diethylpropion is often described as milder and may suit people who are more sensitive to stimulants.
Why Older Appetite Suppressants Still Matter
1. Not Everyone Tolerates GLP 1 Medicines
Gastrointestinal side effects are the most common reason people struggle with GLP 1 therapy. Nausea, vomiting, diarrhoea, constipation and reflux can be significant, particularly during dose increases. For some patients, these effects are temporary. For others, they become a reason to stop treatment altogether.
Phentermine and diethylpropion work through a completely different pathway. Their side effects, such as dry mouth, insomnia and a raised heart rate, are different in nature, so a person who cannot tolerate one class of medicine may do well with the other.
2. Some Patients Prefer Tablets
Needle aversion is more common than many people realise. Even with modern pen devices, some patients feel anxious about weekly injections or simply prefer the familiarity of a tablet. Oral options offer a practical route into treatment for these individuals.
Oral GLP 1 options are also becoming more widely available, and people who want a newer oral medicine can explore Daily Weight Loss Tablets. However, traditional appetite suppressants remain a simpler, lower cost oral choice for suitable patients.
3. Cost and Access Remain Real Barriers
GLP 1 treatments can be expensive when paid for privately, and NHS access is limited by strict eligibility criteria and phased rollouts. Supply shortages in recent years have also left some patients unable to continue their treatment reliably.
Phentermine and diethylpropion are considerably cheaper. For people who are not eligible for NHS treatment and cannot commit to the ongoing cost of injections, a short, affordable course of an appetite suppressant may make treatment accessible for the first time.
4. A Short, Structured Course Suits Some Goals
GLP 1 medicines are increasingly viewed as long term treatments. Research has shown that many people regain a significant portion of their lost weight after stopping. For some patients, the idea of indefinite medication is not appealing.
Older appetite suppressants are designed around a defined course. This can suit people who want a focused period of support to break unhelpful eating patterns, build new routines and gain momentum. When paired with strong lifestyle support, a short course can act as a catalyst rather than a permanent dependency.
5. Rapid Onset of Action
GLP 1 treatments are usually started at a low dose and increased gradually over several weeks to limit side effects. This means meaningful appetite control may take time to develop.
Phentermine and diethylpropion typically begin reducing appetite within the first few days. For motivated patients, early results can boost confidence and reinforce healthier habits from the outset.
6. A Useful Option During Treatment Breaks
Some patients pause GLP 1 therapy because of cost, supply problems, side effects or planned life events. Clinicians may consider a short course of an appetite suppressant in selected cases to help maintain structure during these periods, provided it is clinically appropriate and carefully supervised. Medicines should never be combined without specialist guidance.
What Does the Evidence Say?
Clinical studies generally show that phentermine and diethylpropion produce average weight loss of around 5 percent or more of body weight during treatment, when combined with lifestyle change. Some longer studies of diethylpropion have reported reductions approaching 10 percent over a year, and observational data on phentermine suggest many patients achieve clinically meaningful results.
These figures are lower than the headline results from GLP 1 trials. However, a 5 to 10 percent reduction in body weight is still clinically valuable. It can improve blood pressure, blood sugar control, cholesterol levels, joint pain and sleep apnoea. For many people, modest weight loss produces a genuine improvement in health and quality of life.
Safety Considerations Clinicians Must Respect
The value of older appetite suppressants depends entirely on responsible prescribing. Because they are stimulants, they are unsuitable for people with:
- Heart disease, arrhythmias or a history of stroke
- Uncontrolled high blood pressure
- Overactive thyroid
- Glaucoma
- A history of drug or alcohol misuse
- Severe anxiety or agitation
- Pregnancy or breastfeeding
- Recent use of monoamine oxidase inhibitors
A thorough consultation, baseline blood pressure and heart rate checks, regular reviews and clear stopping rules are essential. Any reputable Weight Loss Clinic should document the clinical reasoning for prescribing an unlicensed medicine and ensure the patient fully understands the benefits and risks.
Patients should report symptoms such as chest pain, palpitations, breathlessness, fainting or ankle swelling immediately, as rare but serious complications have been linked with this class of medicine.
Choosing the Right Treatment: A Personalised Approach
The future of obesity care is not about one medicine replacing all others. It is about matching the right treatment to the right person at the right time. Key factors include:
- Medical history: Cardiovascular health, mental health and existing conditions shape what is safe.
- Goals: Some people need substantial long term weight loss, while others want a short, focused reset.
- Preferences: Tablets versus injections, daily versus weekly dosing.
- Budget: Ongoing affordability matters for sustained success.
- Response: If one treatment does not work or is poorly tolerated, another may.
For suitable patients, Phentermine & Diethylpropion Tablets UK services offer a supervised, oral pathway that sits alongside newer treatments rather than competing with them.
The Role of Lifestyle Support
No medication works in isolation. Appetite suppressants reduce hunger, but lasting results depend on the habits built during treatment. The most effective programmes include nutrition guidance focused on protein, fibre and portion awareness; regular physical activity tailored to ability; strategies for emotional and stress related eating; sleep improvement; and planned follow up after the course ends.
Providers such as Weight Medics combine medical oversight with practical support, helping patients use the treatment window to create sustainable change.
Frequently Asked Questions
Are phentermine and diethylpropion still used in obesity care?
Yes. Although GLP 1 medicines have become more popular, phentermine and diethylpropion are still prescribed for suitable patients who prefer oral treatment, cannot tolerate injections or want a short, affordable course.
Are older appetite suppressants as effective as GLP 1 injections?
On average, GLP 1 treatments produce greater weight loss. However, phentermine and diethylpropion can still deliver clinically meaningful results of around 5 to 10 percent of body weight in some patients.
Why would someone choose an appetite suppressant over a GLP 1 medicine?
Common reasons include lower cost, preference for tablets, intolerance of GLP 1 side effects, supply issues and a desire for a short, defined treatment course.
Are phentermine and diethylpropion safe?
They can be safe when prescribed after a full medical assessment and monitored regularly. They are not suitable for people with heart disease, uncontrolled blood pressure or a history of substance misuse.
Can I take phentermine with a GLP 1 medicine?
Combining weight loss medicines should only ever be considered under specialist supervision. Never combine treatments on your own.
How quickly do appetite suppressants work?
Most people notice reduced appetite within the first few days of treatment.
Will I regain weight after stopping?
Weight regain can happen with any weight loss medicine if old habits return. Using the treatment period to build lasting routines greatly improves long lasting success.
Are these medicines licensed in the UK?
Neither currently holds a UK marketing authorisation. They can be prescribed privately as unlicensed medicines by qualified clinicians.
Final Thoughts
GLP 1 medicines have rightly earned their place at the centre of modern obesity care, but they are not the whole story. Phentermine and diethylpropion continue to offer real value as oral, affordable, fast acting options for carefully selected patients. When prescribed responsibly within a structured programme, they widen access to treatment and give people another route to better health. The goal is not to choose old over new, but to ensure every patient has the option that truly fits their needs.
This article is for general information only and does not replace personal medical advice. Always consult a qualified healthcare professional before starting any weight loss medication.
